Lupin's Famotidine ANDA217432 Receives Abbreviated Approval from FDA
Lupin has received an Abbreviated Approval (AP) for its ANDA217432 application for Famotidine.
Asset / Drug
Drug and asset intelligence for Famotidine with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
H2 Antagonist
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.